Antiretroviral therapy coverage for PMTCT in Guinea-Bissau
Guinea-Bissau: Antiretroviral therapy coverage for PMTCT was 79.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Guinea-Bissau, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Guinea-Bissau stood at 79.0%.
Compared with earlier readings it is up 29.5% on the previous year and down 21.0% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Guinea-Bissau peaked at 100.0% in 2014 and was at its lowest, 0.0%, in 2000.
Guinea-Bissau ranks 43rd of 84 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Guinea-Bissau, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 8.0% | — |
| 2007 | 8.0% | +0.0% |
| 2008 | 4.0% | -50.0% |
| 2009 | 11.0% | +175.0% |
| 2010 | 17.0% | +54.5% |
| 2011 | 24.0% | +41.2% |
| 2012 | 37.0% | +54.2% |
| 2013 | 61.0% | +64.9% |
| 2014 | 100.0% | +63.9% |
| 2015 | 89.0% | -11.0% |
| 2016 | 87.0% | -2.2% |
| 2017 | 87.0% | +0.0% |
| 2018 | 65.0% | -25.3% |
| 2019 | 80.0% | +23.1% |
| 2020 | 81.0% | +1.2% |
| 2021 | 60.0% | -25.9% |
| 2022 | 62.0% | +3.3% |
| 2023 | 61.0% | -1.6% |
| 2024 | 79.0% | +29.5% |
Guinea-Bissau compared with similar countries
- Guinea-Bissau's 79.0% is above the median for low income countries, which is 73.0%, 1.1× the median. (22 countries reporting)
- Guinea-Bissau's 79.0% is below the median for Sub-Saharan Africa, which is 82.0%, 96% of the median. (41 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.1% | 0.0% | 11.0% | 10 |
| 2010s | 64.7% | 17.0% | 100.0% | 10 |
| 2020s | 68.6% | 60.0% | 81.0% | 5 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,070 deaths per 1,000 people (2090)
- Number of infants who die before age 1 941 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.899 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0664 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.8987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Guinea-Bissau?
- Antiretroviral therapy coverage for pmtct in Guinea-Bissau was 79.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Guinea-Bissau?
- The highest recorded value was 100.0% in 2014.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Guinea-Bissau?
- The lowest recorded value was 0.0% in 2000.
- How does Guinea-Bissau rank for antiretroviral therapy coverage for pmtct?
- Guinea-Bissau ranks 43rd out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Guinea-Bissau?
- Over the last ten years it is down 21.0%. The long-run trend across the full record is volatile.
- Where does this Guinea-Bissau data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).